stockrowClearPoint Neuro, Inc. (CLPT) vs CapsoVision, Inc. (CV)
- ClearPoint Neuro, Inc. CLPT 8.52 −1.96%
- CapsoVision, Inc. CV 6.37 +2.74%
ClearPoint Neuro, Inc. and CapsoVision, Inc. are both Medical Devices companies. CapsoVision, Inc. is the larger, with a market value of $329.9M against $278.6M — 1.2× the size. ClearPoint Neuro, Inc. grew revenue faster over the last twelve months: 32.5% against 16.7%. ClearPoint Neuro, Inc. has the higher net margin (−79.4% vs −214.7%) and the higher return on invested capital (−62.8% vs −460.9%). Across the 17 metrics below, ClearPoint Neuro, Inc. leads on 12 and CapsoVision, Inc. on 5.
Valuation
Profitability
| Metric | CLPT | CV | Medical Devices median |
|---|---|---|---|
| Gross margin | 61.39% | 50.88% | 57.76% |
| Operating margin | (70.56%) | (217.09%) | (15.07%) |
| Net margin | (79.43%) | (214.74%) | (14.45%) |
| Free cash flow margin | (73.02%) | (200.77%) | (3.88%) |
| Return on equity | (167.52%) | 47.42% | (10.35%) |
| Return on assets | (41.75%) | (212.19%) | (17.26%) |
| Return on invested capital | (62.84%) | (460.93%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack